Clinical Trial Update: Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TAK-438 (vonoprazan) to lansoprazole for maintenance therapy in healed erosive esophagitis; the update reports efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• Lansoprazole (Lansoprazole)
• TAK-438 (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED